BPC 157 Dosing (Common Protocols), Oral Subcutaneous, 500 mcg daily, Duration: 6 weeks, Intramuscular Peritendinous, 1 mg daily, Duration: 6 weeks, Note:, Not approved by FDA or Is BPC 157 Banned? Oral vs. Injectable Forms Explained Too often, BPC 157 gets boxed into a single use: injury recovery. Gabriel Alizaidy, MD, MS Sublingual BPC 157 TruHealth Physical Therapy OPTIMIZATION DAY , Switching from oral capsules to local sub cutaneous injection of BPC 157 to try and increase my bodys recovery capabilities since suffering a forearm tendon injury. , Ive been BPC 157 Tablets Vs Injection: Benefits, Risks + Comparison